Next-Gen MS: Feed-forward PRO Data for MS Research

Merck KGaA (EMD Serono)

Status: Terminated

Conditions: Multiple Sclerosis (MS)

Study type: Observational

Funder types: Industry

Identifiers

NCT04907305

MS200077_0013

Details and patient eligibility

About

This Next Generation learning health system for Multiple Sclerosis (Next-Gen MS) study is a sub-study of the MS-LINK™ Outcomes Study (NCT04735406). The study aims to examine the effects of using feed forward Patient Reported Outcomes (PROs) data in real-world Multiple Sclerosis (MS) care settings. The study will be conducted within an emerging Learning Healthcare System (LHS).

Enrollment: 1,594 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Participants willing and able to provide written informed consent
• Participants with clinical diagnosis of Multiple Sclerosis (MS)

Exclusion criteria

• None

Trial design

1,594 participants in 2 patient groups

Feed-forward PRO

Description:

Participants in this group will participate in monthly learning collaborative webinars. Feed-forward of patient reported outcomes (PRO) data collected from the main study (NCT04735406) will be used.

Control Group (Usual Care)

Description:

Participants in the control group will receive usual care practices during the clinical encounters.